Navigation Links
Combination therapy shows promising results in patients with advanced lung cancer

An early phase study pairing an experimental targeted therapy with a common anti-inflammatory produced promising results in patients with advanced lung cancer, researchers at UCLA's Jonsson Cancer Center reported.

Pairing the targeted therapy Tarceva with the anti-inflammatory drug Celebrex increased response rates in lung cancer patients by about three-fold, said Dr. Karen Reckamp, an assistant professor of hematology/oncology and lead author of the study. The research appears in the June 1 issue of Clinical Cancer Research, the peer-reviewed journal of the American Association of Cancer Research.

Previous laboratory studies at UCLA showed that a cell signaling pathway known as COX-2 may be linked to resistance to drugs like Tarceva, which block tumor cell growth by targeting the protein EGFR, or epidermal growth factor receptor. Researchers theorized that giving Tarceva with Celebrex, a COX-2 inhibitor, would help battle resistance and prove to be an affective combination against lung cancer.

Typically, about 10 percent of lung cancer patients respond to Tarceva. In Reckamp's study of the combination therapy, about 33 percent of patients responded.

"Tarceva alone is a great drug and has a lot of clinical benefits, but for a small proportion of patients," Reckamp said. "With this drug combination, we saw an increase in response rates, indicating we are overcoming some resistance. We also may be beginning to understand the mechanisms of that resistance."

Volunteers in the Phase I study, patients with advanced lung cancer that had failed to respond to all conventional therapies, took several Celebrex pills and one Tarceva pill each day. After eight weeks, researchers looked at response rates. Patients were able to stay on the study as long as they didn't experience tumor growth. The longest duration of response was 93 weeks, Reckamp said, about three to four times longer than the average duration of response for a patient with
'"/>

Source:University of California - Los Angeles


Page: 1 2 3

Related biology news :

1. Combination therapy boosts effectiveness of telomere-directed cancer cell death
2. Combination therapy leads to partial recovery from spinal cord injury in rats
3. Combination therapy improves AIDS-related lymphoma outcome
4. Combination therapy with a monocloncal antibody and a vaccine leads to tumor rejection
5. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
6. Columbia research lifts major hurdle to gene therapy for cancer
7. Gene therapy converts dead bone graft to new, living tissue
8. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
9. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
10. Muscle-targeted gene therapy reverses rare muscular dystrophy in mice
11. New therapy for HIV/AIDS eliminates needles and excessive toxicity
Post Your Comments:
(Date:7/2/2009)...tists are to study a group of proteins that are hi... hold the key to developing new types of antibioti...and Leeds have been awarded 3.3m from the Biotechn...SRC) to find out how a family of proteins known as...ore destroying them. , The team, led by Professo...
(Date:7/2/2009)...GINIA KEY, Fla. As the nation celebrates its birt...fessor Diego Lirman and fellow Caribbean coral ree... The National Oceanic and Atmospheric Administrati...ncy and its partners, staghorn and elkhorn coral r...cayne National Park, will receive support from the...
(Date:7/1/2009)...y diseases including plague, Ebola and Rift Valley...illion pound international partnership involving A...velopment Centre (LIDC). The Southern African Cent...nks medical and veterinary institutions from five ...ty of African institutions to detect, identify and...
(Date:7/1/2009)...viously, only a few genes had been associated with... Now, researchers of the Max Delbrck Center for Mo...versity Medicine Berlin, Germany, have identified ...y tumor and in its metastases. In the future, thei...ive tumors at an earlier stage ( Gastroenterology ...
Breaking Biology News(10 mins):Nursery programs for corals receive TLC from NOAA this Independence Day 2Research network wins approximately £5.7 million to target human and animal diseases in Africa 2Research network wins approximately £5.7 million to target human and animal diseases in Africa 3Colorectal cancer 2Genetic differences in clover make one type toxic 627 1Genetic differences in clover make one type toxic 627 2Genetic differences in clover make one type toxic 627 3Medicare Offers Smallest Rise in Premiums in 6 Years 2507 1Medicare Offers Smallest Rise in Premiums in 6 Years 2507 2Medicare Offers Smallest Rise in Premiums in 6 Years 2507 3Grosse Pointes Cottage Hospital Joins Henry Ford Health System 2503 1Grosse Pointes Cottage Hospital Joins Henry Ford Health System 2503 2Grosse Pointes Cottage Hospital Joins Henry Ford Health System 2503 3CRN Announces Syndication Launch for Recovery Talk Network 2499 1CRN Announces Syndication Launch for Recovery Talk Network 2499 2
...ve discovered that the human immunodeficiency viru...efforts to destroy it by hiding out in the mucosal...V continues to replicate in the gut mucosa, suppre...th antiretroviral therapy--even when blood samples... was working. Results of the three-year study appe...
...roducing cellular energy, the glycolytic pathway, ...cancer therapies. , A team of Harvard Medical Sch...way,s enzymes, LDHA, in a variety of fast-growing ...colysis, and implanted the cells in mice. Control ...ytic pathway did not survive beyond 10 weeks. In s...
...stroyed Mesopotamian marshes since 2003 has result...tive invertebrates, plants, fish, and birds, accor.... , Curtis J. Richardson of Duke University and N...ng about fieldwork conducted over the past two yea...at water inflow from the Tigris and Euphrates rive...
...les that convert laser light into useful informati...rld,s first nano-sized pH meter. , The discovery, ... Letters, presents biologists with the first poten... wide pH range in real-time inside living tissue a...comes up with one or two things they,d like to mea...
Other Biology News:UC Davis study finds HIV hiding from drugs in gut, preventing immune recovery 2UC Davis study finds HIV hiding from drugs in gut, preventing immune recovery 3Attacking cancer's sweet tooth is effective strategy against tumors 2Attacking cancer's sweet tooth is effective strategy against tumors 3Iraq's marshes show progress toward recovery 2Rice scientists make first nanoscale pH meter 2
(Date:6/30/2009)...if. and HONG KONG, June 30 /PRNewswire-FirstCall/ ... announced today that Excalibur,s Ocean LaLa has s...passenger voyage which has been highlighted in mul...ding the Taiwan Sun, and the Qatar Tribune. The a...a cruise service with China on Sunday, making it t...
(Date:6/30/2009)...ll/ -- VEGA PROMOTIONAL SYSTEMS, INC. (Pink Sheets... TN based consulting firm, Tennessee Power Company... production facility in Georgia. , , Vega rec...lant in Georgia to take advantage of the abundance...ridor. Georgia ranks third in the nation as a pot...
(Date:6/30/2009)...une 30 Microfluidics, a wholly own...ration (OTC Bulletin Board: MFLU), and Particle Sc... to help biopharmaceutical companies leverage the ...ulation methods available to develop, analyze and ...PIs). , , Particle Sciences is a leading Contra...
(Date:6/30/2009)...-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) ann...proprietary, recombinant virus-like-particle (VLP)...d: ROVI) of Spain. ROVI will use the VLP technolo...ution for the Spanish government under a new 60 mi...h Ministry of Health and other government groups t...
Breaking Biology Technology:Excalibur International Marine (49% Owned by EFT BioTech Holdings) Completes Inaugural Passenger Crossing of Taiwan Strait 2Excalibur International Marine (49% Owned by EFT BioTech Holdings) Completes Inaugural Passenger Crossing of Taiwan Strait 3Vega Picks Tennessee Firm to Assist with Construction of Biomass Plant in Georgia 2Particle Sciences and Microfluidics Collaborate to Share Formulation and Nanotechnology Expertise for Pharmaceutical Drug Product Development, Analysis and Commercialization 2Particle Sciences and Microfluidics Collaborate to Share Formulation and Nanotechnology Expertise for Pharmaceutical Drug Product Development, Analysis and Commercialization 3Spanish Government Selects Novavax's VLP Technology for Comprehensive Flu Vaccine Solution in Spain 2Spanish Government Selects Novavax's VLP Technology for Comprehensive Flu Vaccine Solution in Spain 3Spanish Government Selects Novavax's VLP Technology for Comprehensive Flu Vaccine Solution in Spain 4Spanish Government Selects Novavax's VLP Technology for Comprehensive Flu Vaccine Solution in Spain 5
...ermany - A "sister park" agreement has been annou...ark and the Frankfurt Biotechnology Innovation Ce...s hubs. , ,A memorandum of understanding between t...W-Madison Chancellor John Wiley, University Resear...managing director of the Frankfurt Biotechnology I...
...s. GE Healthcare announced today that Rockwoo...acilities in the Spokane, Washington area, has pur...e products. , ,One of the new technologies the cli...ll allow patients to schedule appointments, update...onically. The patient can take an active role in u...
.... - The Department of Commerce (Commerce) has qua...its under the new Angel Investor and Venture Fund ...through tax credits to make these crucial investme... viable, job-creating businesses," Gov. Jim Doyle ...Credit Programs offer Wisconsin income tax credits...
... The National Committee for Quality Assurance (...hysician Office system as the first electronic hea... who wish to pursue the NCQA/ American Diabetes As...(DPRP). , ,To qualify for DPRP recognition, physi...r patient files and calculate the percentage of th...
Other Biology Technology:Five technology companies qualify for investor tax credits 2
...ple and efficient means for isolation of apoptotic...c beads (MagBeads). Annexin V is a Ca2+-dependent ...r phosphatidylseri The Apoptotic Cell Isolation K...tion of apoptotic cells or removal of dead cells f...
Application: A tracking dye for nucleic acid electrophoresis in agarose or polyacrylamide gels including DNA sequencing. Preparation Quantity Equivalency: A final concentration of 0.05% is recommende
...d to be a solid, heavy-duty durable orbital shaker...nd vortexing in nature. The VSOS-4 Orbital Shak...orm orbital shaking motion (19mm circular) for a w...tissue culture, hybridization, staining and destai...
...er combines top performance with exquisite design....unparalleled temperature uniformity. The instrumen...g in a spreadsheet or alternatively in a graphical... push of a button and swings in a defined end posi...
Biology Products: